Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Diana Cirstea
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells
PLoS ONE
Multidisciplinary
Related publications
Molecular Signaling in Multiple Myeloma: Association of RAS/RAF Mutations and MEK/ERK Pathway Activation
Oncogenesis
Cancer Research
Molecular Biology
Prohibitins Role in Cellular Survival Through Ras-Raf-Mek-Erk Pathway
Journal of Cellular Physiology
Clinical Biochemistry
Cell Biology
Physiology
Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)
Oncology Letters
Cancer Research
Oncology
Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor
Cancer immunology research
Cancer Research
Immunology
Modulation of the Akt/Ras/Raf/Mek/Erk Pathway by A3 Adenosine Receptor
Purinergic Signalling
Molecular Neuroscience
Cell Biology
Molecular Biology
Cellular
MicroRNA‑98 Suppresses Cell Growth and Invasion of Retinoblastoma via Targeting the IGF1R/k‑Ras/Raf/MEK/ERK Signaling Pathway
International Journal of Oncology
Cancer Research
Oncology
Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway
Cancer Management and Research
Oncology
Epigallocatechin-3-Gallate Inhibits the Growth and Increases the Apoptosis of Human Thyroid Carcinoma Cells Through Suppression of EGFR/RAS/RAF/MEK/ERK Signaling Pathway
Cancer Cell International
Cancer Research
Oncology
Genetics
Correction: Amphiregulin Enhances Alpha6beta1 Integrin Expression and Cell Motility in Human Chondrosarcoma Cells Through Ras/Raf/Mek/Erk/Ap-1 Pathway
Oncotarget
Oncology
